Skip to content

Perbak Capital Partners LLP: TPH position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Perbak Capital Partners LLP on TPH, newest first. How the timeline and the estimate are built.

Perbak Capital Partners LLP held 0 TPH shares at 2026-03-31 per its 13F-HR filed 2026-05-15.

the latest 13F is the newest step

  1. period ended2026-03-31
    13F 0 shares
    Change vs previous 13F -13,564 shares

    13F-HR 0000902664-26-002476 filed by Perbak Capital Partners LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-12-31
    13F 13,564 shares
    Change vs previous 13F -27,671 shares

    0.13% of the 13F portfolio, value $426,859.

    13F-HR 0000902664-26-001029 filed by Perbak Capital Partners LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-09-30
    13F 41,235 shares
    Change vs previous 13F +14,692 shares

    0.25% of the 13F portfolio, value $1,400,753.

    13F-HR 0000902664-25-004905 filed by Perbak Capital Partners LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-06-30
    13F 26,543 shares
    Change vs previous 13F +15,192 shares

    0.19% of the 13F portfolio, value $848,049.

    13F-HR 0000902664-25-003680 filed by Perbak Capital Partners LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-03-31
    13F 11,351 shares
    Change vs previous 13F not available

    0.27% of the 13F portfolio, value $362,324.

    13F-HR 0000902664-25-002434 filed by Perbak Capital Partners LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).